Withdrawal of Life Support in the Neurological Intensive Care Unit
Neurol 52:1602-1609,1538, Mayer,S.A.&Kossoff,S.B., 1999
End-of-Life Care,A Survey of US Neurologists' Attitudes, Behavior, and Knowledge
Neurol 53:284-293, Carver,A.C.,et al, 1999
Assisted Suicide
Euthanasia, and the Neurologist, The Ethics and Humanities Subcom of AAN, Neurol 50:596-59898., , 1998
Withdrawing Intensive Life-Sustaining Treatment-Recommendations for Compassionate Clin Mgmt
NEJM 336:652-657, Brody,H.,et al, 1997
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Patients in the Persistent Vegetative State:Problems in Their Long Term Management
BMJ 306:1600-1603, Andrews,K., 1993
Position Stmt:Care & Management of Prof & Irreversibly Paralyzed Pts with Retained Conscious & Cognit
Ethics & Human Subcom of AAN, Neurol 43:222-22393., , 1993
Competent Pts with Adv States of Perm Paralysis Have the Right to Forgo Life-Sustaining Therapy
Neurol 43:224-225, Bernat,J.L.,et al, 1993
When Life Support is Questioned Early in the Care of Patients with Cervical-Level Quadriplegia
NEJM 328:506-509, Patterson,D.R.,et al, 1993
Withdrawing Life-Sustaining Treatment, lessons from Nancy Cruzan
Arch Int Med 152:25-27, Fairman,R.P., 1992
Persistent Vegetative State and the Right to Die:The United States and Britain
BMJ 302:1256-1258, Jennett,B.&Dyer,C., 1991
Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Hereditary Hemorrhagic Telangiectasia, Clinical Presentations, and Management
Stroke 54:e512-e515, Silveira,L.,et al, 2023
The Neural Networks Underlying the Illusion of Time Dilation
Ann Neurol 91:295-297, Sheikh, M.M.,et al, 2022
Association of Atrial Septal Aneurysm and Shunt Size with Stroke Recurrence and Benefit From Patent Foramen Ovale Closure
JAMA Neurol 79:1175-1179, Mas,J-L.,et al, 2022
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Recurrent Cerebral Ischemia During Pregnancies
Neurol 95:e2453-e2457, Bulwa, Z.,et al, 2020
The role of infarct location in patients with DWI-ASPECTS 0-5 acute stroke treated with thrombectomy
Neurol 95:e3344-e3354,1078, Panni, P.,et al, 2020
Pyogenic Brain Abscesses in a Patient with Digital Clubbing
JAMA Neurol 77:129-130, Paliwal, V.K.,et al, 2020
May-Thurner Syndrome as a Cause of Embolic Stroke of Undetermined Source in a Young Patient
Neurol 92:e2507-e2509, De Leon-Benedetti, A.,et al, 2019
Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018
Association of Preoperatively Diagnosed Patent Foramen Ovale with Perioperative Ischemic Stroke
JAMA 319:452-462,446, Ng, P.Y.,et al, 2018
Headache and Altered Mental Status
Neurol 90:e1267-e1270, Spera, K.M.,et al, 2018
PFO Closure for Cryptogenic Stroke
NEJM 378:1639-1642, Mi, M.Y.,et al, 2018
Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018
Complex Bilateral Corpus Callosum Infarction after Paradoxical Embolism
Neurol 91:e1947-e1948, Calheiros de Oliveira Costa, G.V.,et al, 2018
Increased Risk of Traffic Injury After a Cerebrovascular Event
Stroke 49:3006-3011, Yu, A.Y.X.,et al, 2018
A 45-year-old Woman with Right Limb Weakness
Neurol 88:e103-e107, Li, S.,et al, 2017
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017
Clinicopathologic Conference, Acute Ischemic Stroke, Caused by Paradoxical Embolism Through a Patent Foramen Ovale, in a Patient with the May-Thurner Syndrome and a Hypercoagulable State Due to an Occult Renal-Cell Carcinoma
NEJM 374:1671-1680, Case 13-2016, 2016
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016
Stroke in Commercial Flights
Stroke 47:1117-1119, Alvarez-Velasco, R.,et al, 2016
Clinicopathologic Conference, Cerebral Infarction from Internal Carotid Occlusion Related to Sickle Cell Arteriopathy
NEJM 374:1265-1275, Case 10-2016, 2016
Cardioembolic Stroke in Adults with a History of Congenital Heart Disease
Stroke 47:e79-e81, Attar, H.,et al, 2016
The Value of Transesophageal Echocardiography for Embolic Strokes of Undetermined Source
Neuol 87:988-995, Katsanos, A.H.,et al, 2016
Risk of Recurrent Neurologic Stroke or Transient Ischemic Attack in Patients with Cryptogenic Stroke and Intrapulmonary Shunt
Echocardiography 33:276-280, Sinha, R.S.,et al, 2015
Acute Ischemic Stroke in Pediatric Patients
Stroke 46:e32-e33, Mittal, S.O.,et al, 2015
Cryptic Loss of Consciousness in a 36-Year-Old Woman
Stroke 46:e164-e166, Martinez Majander, N.,et al, 2015
A 50-year-old Man with "Elephantiasis" and Headache
Neurol 85:e52-e55, Yaghi, S.,et al, 2015
Clinical Outcomes after Neurogenic Stress Induced Cardiomyopathy in Aneurysmal Sub-Arachnoid Hemorrhage: A Prospective Cohort Study
Clin Neurol Neurosurg 128:4-9, Kilbourn, K.J.,et al, 2015
Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 45:2324-2329, Liberman, A.L.,et al, 2014
Red Papules on the Tongue of a Patient with Hemiparesis
JAMA 312:741-742, Chiu, H.Y. & Lin, S.J., 2014
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013